SOLID TUMOR

We provide targeted DNA sequencing allowing us to focus specific areas of interest at a reduced price and faster delivery time. Our laboratory’s technology can accommodate small blood sample sizes, making it viable alternative to a trip to the phlebotomist and reducing the impact of blood-drawing on patients’ health. This assay is performed using small amounts of genomic DNA taken from fresh frozen or paraffin-embedded tumor tissue.

SOLID TUMOR

NEXT GENERATION SEQUENCING – SOMATIC MUTATION

Sequencing of genes associated with solid tumor cancers can provide valuable information that may lead to targeted therapies. Our Tumor Panel takes a deeper view of genetic variants in solid tumors such as lung cancer, colon cancer, melanoma, gastric cancer and ovarian cancer. The assay provides highly accurate variant analysis at limit of detection below 5% variant allele frequency across 174 amplicons, with 1000x minimum coverage of each region. This assay is performed using small amounts of genomic DNA taken from fresh frozen or paraffin-embedded tumor tissue.

AKT1
ALK
APC
BRAF
CDH1
CTNNB1
EGFR
ERBB2
FBXW7
FGFR2
FOXL2
GNAQ
GNAS
KIT
KRAS
MAP2K1
MET
MSH6
NRAS
PDGFRA
PIK3CA
PTEN
SMAD4
SRC
STK11
TP53

All tests are performed in Ayass BioScience, LLC (DBA Ayass Lung Clinic, PLLC). Ayass BioScience, LLC is a CLIA certified laboratory. If you have any questions about Genetic Testing Next Generation Sequencing at Ayass BioScience, LLC, please call today at 972-668-6005 or fill out our contact form on the bottom of this page. We will answer any question you might have.